Organ Regeneration?

Discussion in 'Health and Lifestyle' started by woodyvoinche, Oct 20, 2005.

  1. woodyvoinche
    Offline

    woodyvoinche Member

    Joined:
    Oct 10, 2005
    Messages:
    53
    Thanks Received:
    1
    Trophy Points:
    6
    Ratings:
    +1
    :whip3: There is an interesting article on Therapeutic Cloning and Telomerase...by Dr. Michael West in the November issue of LIFE EXTENSION magazine... www.lef.org ...as a technology for rejuvenating diseased organs.

    The use of adult stem cells and cell culturing and the injecting of these into damaged tissue
    has been addressed in other media outlets. The company Bioheart
    Inc...www.bioheartinc.com...
    has been involved in clinical trials in Europe...extracting part of a
    heart
    patient's thigh muscle...
    concentrating immature muscle cells...and injecting them back into
    damaged
    hearts of the patient...


    Other reports of adult stem cells from blood, umbilical cord blood,
    etc...and the abilitiy of these to
    transform into insulin producing cells, regeneration of nerve , lung,
    liver, skin, etc...

    And the work of Dr. J. Vacanti in tissue engineering and his isolation
    of
    "sporelike cells" or adult
    stem cells out of diabetic pancreas and sheep lung and the regeneration
    of
    the lung after part of
    it had been cut out...DISCOVER magazine, July
    2001...... http://www.pbs.org/saf/1107/features/body.htm ...
    also this
    scientific american site...... http://www.sciam.com/mastertech/langer.pdf .....
    It would be interesting to know what other clinical trials are occurring
    in Europe and other countries
    in this area...

    woody voinche
     
  2. waltky
    Offline

    waltky Wise ol' monkey Supporting Member

    Joined:
    Feb 6, 2011
    Messages:
    20,804
    Thanks Received:
    1,789
    Trophy Points:
    215
    Location:
    Okolona, KY
    Ratings:
    +3,865
    Drug to fix DNA gets go-ahead...
    :eusa_clap:
    Drug to fix faulty DNA gets go-ahead in landmark move that may alter medicine forever
    2 November 2012 | Gene therapy drug given green light for rare disease; Glybera to cost £1m ($1.6m) for each patient; Drug is first to get approval in Western world; EU go-ahead paves way for many more treatments
     

Share This Page